Skip to main content
B

Beryl Drugs Ltd. — Investor Relations & Filings

Ticker · 524606 ISIN · INE415H01017 LEI · 984500CC594C0ZE90971 BSE.NS Manufacturing
Filings indexed 0 across all filing types
Latest filing no filings yet
Country IN India
Listing BSE.NS 524606

About Beryl Drugs Ltd.

https://www.beryldrugs.com/

Beryl Drugs Ltd. focuses on the manufacturing and marketing of formulations, specializing in intravenous (IV) fluids and small volume parenterals. The company produces a diverse range of medical solutions, including electrolyte replacements such as Dextrose and Sodium Chloride, alongside therapeutic injectables like Ciprofloxacin and Metronidazole. Its operations center on providing critical care products for clinical and hospital environments. The product portfolio covers multiple therapeutic categories, emphasizing the production of sterile liquid medications designed for patient treatment and recovery.

Recent filings

No filings indexed yet

We are still gathering filings for Beryl Drugs Ltd.. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.